Results 31 to 40 of about 15,131,393 (64)

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

open access: yesThe Lancet
Summary Background Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable ...
M. Naghavi   +499 more
semanticscholar   +1 more source

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

open access: yesLancet Neurology
Summary Background Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning. We aimed to provide such
Valery L. Feigin   +499 more
semanticscholar   +1 more source

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

open access: yesThe Lancet
Summary Background Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand ...
Austin E. Schumacher   +499 more
semanticscholar   +1 more source

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

open access: yesThe Lancet
BACKGROUND Semaglutide, a GLP-1 receptor agonist, reduces the risk of major adverse cardiovascular events (MACE) in people with overweight or obesity, but the effects of this drug on outcomes in patients with atherosclerotic cardiovascular disease and ...
J. Deanfield   +499 more
semanticscholar   +1 more source

Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study.

open access: yesi Medicina
BACKGROUND Immune checkpoint inhibitors (ICIs) have shown limited success in glioblastoma due to the tumor's profoundly immunosuppressive microenvironment.
Dongjiang Chen   +7 more
semanticscholar   +1 more source

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

open access: yesi Medicina
BACKGROUND Thymic epithelial tumors (TETs) are rare malignancies with limited treatment options and underexplored molecular features. METHODS We examined the genomic landscape and therapeutic outcomes in 81 patients with advanced TETs, including thymic
L. Möhrmann   +48 more
semanticscholar   +1 more source

Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050

open access: yesi Medicina
Summary Background This study aims to estimate the burden, trends, forecasts, and disparities of early musculoskeletal (MSK) disorders among individuals ages 15 to 39 years.
Yingzhao Jin   +456 more
semanticscholar   +1 more source

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

open access: yesNature, 2021
E. Volz   +499 more
semanticscholar   +1 more source

Halley's comet of 87 BC on the coins of Armenian king Tigranes? [PDF]

open access: yesAstronomy and Geophysics, 2004
Coins of Armenian king Tigranes the Great clearly reveal a star with a tail on the royal tiara which may be associated with the Halley’s passage of 87 BC.
V.G.Gurzadyan, R.Vardanyan
exaly   +2 more sources

Home - About - Disclaimer - Privacy